GLP-1/글루카곤 이중 효능제의 제조 방법
글루카곤 및 GLP-1 이중 효능제 화합물 또는 그의 제약상 허용되는 염의 제조를 위한 중간체 제조물이 본원에 개시된다. 또한, 하이브리드 고체 액체 상 합성을 통해 2 내지 4종의 중간체 제조물을 커플링시킴으로써 글루카곤 및 GLP-1 이중 효능제 화합물을 제조하는 방법이 본원에 개시된다. Disclosed herein are intermediate preparations for the manufacture of glucagon and GLP-1 dual agonist compounds or pharmaceutically acce...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | kor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | KOPACH MICHAEL EUGENE MURZINSKI EMILY SUZANNE |
| description | 글루카곤 및 GLP-1 이중 효능제 화합물 또는 그의 제약상 허용되는 염의 제조를 위한 중간체 제조물이 본원에 개시된다. 또한, 하이브리드 고체 액체 상 합성을 통해 2 내지 4종의 중간체 제조물을 커플링시킴으로써 글루카곤 및 GLP-1 이중 효능제 화합물을 제조하는 방법이 본원에 개시된다.
Disclosed herein are intermediate preparations for the manufacture of glucagon and GLP-1 dual agonist compounds or pharmaceutically acceptable salts thereof. Also disclosed herein are processes for the manufacture of glucagon and GLP-1 dual agonist compounds by coupling two to four intermediate preparations via hybrid solid liquid phase synthesis. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20240154654A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20240154654A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20240154654A3</originalsourceid><addsrcrecordid>eNrjZDBx9wnQNdR_taPh9eIVb3ZuebV5icKbuVveLJmo8HbWitddS98smPNm7gwFELVwg8LrDStfb5rKw8CalphTnMoLpbkZlN1cQ5w9dFML8uNTiwsSk1PzUkvivYOMDIxMDAxNTcxMTRyNiVMFALlaOqY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>GLP-1/글루카곤 이중 효능제의 제조 방법</title><source>esp@cenet</source><creator>KOPACH MICHAEL EUGENE ; MURZINSKI EMILY SUZANNE</creator><creatorcontrib>KOPACH MICHAEL EUGENE ; MURZINSKI EMILY SUZANNE</creatorcontrib><description>글루카곤 및 GLP-1 이중 효능제 화합물 또는 그의 제약상 허용되는 염의 제조를 위한 중간체 제조물이 본원에 개시된다. 또한, 하이브리드 고체 액체 상 합성을 통해 2 내지 4종의 중간체 제조물을 커플링시킴으로써 글루카곤 및 GLP-1 이중 효능제 화합물을 제조하는 방법이 본원에 개시된다.
Disclosed herein are intermediate preparations for the manufacture of glucagon and GLP-1 dual agonist compounds or pharmaceutically acceptable salts thereof. Also disclosed herein are processes for the manufacture of glucagon and GLP-1 dual agonist compounds by coupling two to four intermediate preparations via hybrid solid liquid phase synthesis.</description><language>kor</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241025&DB=EPODOC&CC=KR&NR=20240154654A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241025&DB=EPODOC&CC=KR&NR=20240154654A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KOPACH MICHAEL EUGENE</creatorcontrib><creatorcontrib>MURZINSKI EMILY SUZANNE</creatorcontrib><title>GLP-1/글루카곤 이중 효능제의 제조 방법</title><description>글루카곤 및 GLP-1 이중 효능제 화합물 또는 그의 제약상 허용되는 염의 제조를 위한 중간체 제조물이 본원에 개시된다. 또한, 하이브리드 고체 액체 상 합성을 통해 2 내지 4종의 중간체 제조물을 커플링시킴으로써 글루카곤 및 GLP-1 이중 효능제 화합물을 제조하는 방법이 본원에 개시된다.
Disclosed herein are intermediate preparations for the manufacture of glucagon and GLP-1 dual agonist compounds or pharmaceutically acceptable salts thereof. Also disclosed herein are processes for the manufacture of glucagon and GLP-1 dual agonist compounds by coupling two to four intermediate preparations via hybrid solid liquid phase synthesis.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBx9wnQNdR_taPh9eIVb3ZuebV5icKbuVveLJmo8HbWitddS98smPNm7gwFELVwg8LrDStfb5rKw8CalphTnMoLpbkZlN1cQ5w9dFML8uNTiwsSk1PzUkvivYOMDIxMDAxNTcxMTRyNiVMFALlaOqY</recordid><startdate>20241025</startdate><enddate>20241025</enddate><creator>KOPACH MICHAEL EUGENE</creator><creator>MURZINSKI EMILY SUZANNE</creator><scope>EVB</scope></search><sort><creationdate>20241025</creationdate><title>GLP-1/글루카곤 이중 효능제의 제조 방법</title><author>KOPACH MICHAEL EUGENE ; MURZINSKI EMILY SUZANNE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20240154654A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>kor</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>KOPACH MICHAEL EUGENE</creatorcontrib><creatorcontrib>MURZINSKI EMILY SUZANNE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KOPACH MICHAEL EUGENE</au><au>MURZINSKI EMILY SUZANNE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>GLP-1/글루카곤 이중 효능제의 제조 방법</title><date>2024-10-25</date><risdate>2024</risdate><abstract>글루카곤 및 GLP-1 이중 효능제 화합물 또는 그의 제약상 허용되는 염의 제조를 위한 중간체 제조물이 본원에 개시된다. 또한, 하이브리드 고체 액체 상 합성을 통해 2 내지 4종의 중간체 제조물을 커플링시킴으로써 글루카곤 및 GLP-1 이중 효능제 화합물을 제조하는 방법이 본원에 개시된다.
Disclosed herein are intermediate preparations for the manufacture of glucagon and GLP-1 dual agonist compounds or pharmaceutically acceptable salts thereof. Also disclosed herein are processes for the manufacture of glucagon and GLP-1 dual agonist compounds by coupling two to four intermediate preparations via hybrid solid liquid phase synthesis.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | kor |
| recordid | cdi_epo_espacenet_KR20240154654A |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | GLP-1/글루카곤 이중 효능제의 제조 방법 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T08%3A28%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KOPACH%20MICHAEL%20EUGENE&rft.date=2024-10-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20240154654A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |